House Democrats Hammer On Arguments Against FDA Pre-Emption

A Supreme Court ruling favoring federal pre-emption for PMA-approved devices will shift the financial burden of faulty devices from manufacturers to U.S. consumers and taxpayers, Congressional Democrats argue

More from Archive

More from Medtech Insight